UK markets closed

Apontis Pharma AG (APPH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
6.72-0.08 (-1.18%)
At close: 09:38AM CEST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
55,280
51,184
39,240
40,035
Cost of revenue
19,773
17,397
14,215
11,064
Gross profit
35,507
33,787
25,025
28,972
Operating expenses
Selling general and administrative
-
4,603
3,540
4,647
Total operating expenses
30,007
32,121
25,640
31,215
Operating income or loss
5,500
1,667
-614.3994
-2,243
Interest expense
50.2949
406
868
828
Income before tax
4,446
248.2642
-1,477
-3,071
Income tax expense
642.6744
993.5295
-294.7336
-678.0017
Income from continuing operations
3,803
-745.2653
-1,183
-2,393
Net income
3,803
-745.2369
-1,183
-2,393
Net income available to common shareholders
3,803
-745.2369
-1,183
-2,393
Basic EPS
-
-0.09
-0.14
-0.28
Diluted EPS
-
-0.09
-0.14
-0.28
Basic average shares
-
8,500
8,500
8,500
Diluted average shares
-
8,500
8,500
8,500
EBITDA
-
2,401
1,045
-1,673